- JP-listed companies
- Kitazato Corporation
- Income statement
Kitazato Corporation (368A) Income statement
Market cap
¥48.6B
P/E ratio
12.3x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 7,428 | 6,766 | 8,140 | 9,348 | 10,080 | 10,302 | 10,947 |
| Revenue growth (%) | - | ||||||
| Cost of revenue | - | - | - | 2,651 | 3,040 | 3,327 | 3,732 |
| Gross profit | - | - | - | 6,697 | 7,040 | 6,974 | 7,214 |
| Gross margin (%) | - | - | - | ||||
| Operating margin (%) | - | - | - | ||||
| Operating expenses | - | - | - | 1,568 | 1,127 | 1,191 | 1,355 |
| Operating income | - | - | - | 5,128 | 5,912 | 5,782 | 5,858 |
| Income before tax | 4,265 | 3,586 | 4,474 | 5,117 | 5,995 | 5,767 | 5,903 |
| Pretax margin (%) | 57.4 | 53 | 55 | 54.7 | 59.5 | 56 | 53.9 |
| Provision for income taxes | - | - | - | 1,734 | 2,022 | 1,952 | 2,009 |
| Effective tax rate (%) | - | - | - | ||||
| Net income | 2,813 | 2,354 | 2,952 | 3,370 | 3,972 | 3,788 | 3,811 |
| Earnings per share | 14 | 12 | 15 | 84.26 | 99.32 | 94.72 | 97.38 |
| Dividend per share | - | - | - | - | - | 41 | 41 |